LaDuane Clifton
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Zevra Therapeutics, Inc. (ZVRA) | MBA, CPA Former Chief Financial Officer and Treasurer | $477,307 | $3,821,924 |
| 2024 | Zevra Therapeutics, Inc. (ZVRA) | MBA, CPA Former Chief Financial Officer and Treasurer | $460,867 | $1,450,273 |
| 2023 | Zevra Therapeutics, Inc. (ZVRA) | MBA, CPA Chief Financial Officer, Secretary and Treasurer | $446,480 | $2,263,257 |
| 2022 | Zevra Therapeutics, Inc. (ZVRA) | MBA, CPA Chief Financial Officer, Secretary and Treasurer | $410,975 | $1,038,007 |
| 2021 | Zevra Therapeutics, Inc. (ZVRA) | Chief financial officer, secretary and treasurer | $370,993 | $1,056,212 |
| 2020 | Zevra Therapeutics, Inc. (ZVRA) | Chief financial officer, secretary and treasurer | $350,200 | $541,114 |
| 2019 | Zevra Therapeutics, Inc. (ZVRA) | Chief financial officer, secretary and treasurer | $348,500 | $664,487 |
| 2018 | Zevra Therapeutics, Inc. (ZVRA) | Chief financial officer, secretary and treasurer | $337,500 | $647,324 |
Executive changes
-
Resigned Chief Financial Officer and Treasurer and principal financial officer at Zevra Therapeutics, Inc. (ZVRA)2025-12-31
Earnings-call appearances
-
Zevra Therapeutics, Inc. Q3 FY2025 Earnings Call2025-11-05
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q2 FY2025 Earnings Call2025-08-12
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q1 FY2025 Earnings Call2025-05-13
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q4 FY2024 Earnings Call2025-03-11
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q3 FY2024 Earnings Call2024-11-12
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q2 FY2024 Earnings Call2024-08-08
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q1 FY2024 Earnings Call2024-05-08
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q4 FY2023 Earnings Call2024-03-28
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q3 FY2023 Earnings Call2023-11-07
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q2 FY2023 Earnings Call2023-08-14
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q1 FY2023 Earnings Call2023-05-15
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q4 FY2022 Earnings Call2023-01-25
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q3 FY2022 Earnings Call2022-11-09
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q2 FY2022 Earnings Call2022-08-11
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q1 FY2022 Earnings Call2022-05-12
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q4 FY2021 Earnings Call2022-03-30
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q3 FY2021 Earnings Call2021-11-10
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q2 FY2021 Earnings Call2021-08-12
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q1 FY2021 Earnings Call2021-05-13
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q4 FY2020 Earnings Call2021-03-11
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q3 FY2020 Earnings Call2020-09-30
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q2 FY2020 Earnings Call2020-08-12
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q1 FY2020 Earnings Call2020-05-12
Zevra Therapeutics, Inc. (ZVRA)